부정방암탕(扶正防癌湯) 구성(構成) 약물(藥物)의 암전이(癌轉移) 억제(抑制)에 대한 연구(硏究)

Anti-metastastic Effects of ingredients of Fuzhengfangaitang

  • Park, Joon-Hyuck (Dept. of Oriental Pathology, College of Oriental Medicine, Kyung Hee University) ;
  • Yu, Young-Beob (Dept. of Oriental Pathology, College of Oriental Medicine, Kyung Hee University) ;
  • Shim, Bum-Sang (Dept. of Oriental Pathology, College of Oriental Medicine, Kyung Hee University) ;
  • Choi, Seung-Hoon (Dept. of Oriental Pathology, College of Oriental Medicine, Kyung Hee University) ;
  • Ahn, Koo-Seok (Dept. of Oriental Pathology, College of Oriental Medicine, Kyung Hee University)
  • 발행 : 2001.12.30

초록

Fuzhengfangaitang is a prescript for inhibiting recurrence and metastasis of cancer. We had examined the anti-metatstastic effect of Fuzhengfangaitang. Furthermore, we performed the following experiments with ingredients of Fuzhengfangaitang. The purpose of this thesis is to study what ingredients of Fuzhengfangaitang have more valuable anti-cancer effects. And the results are listed below: 1. Cell Viability assay At the dose of 400$\mu$g/ml, most ingredients of Fuzhengfangaitang depressed viability of ECV-304. And especially, Scutellaria barbata D. DON$50{\mu}g/ml$ : 53.118%, $100{\mu}g/ml$: 49.092%, $200{\mu}g/ml$ : 43.765%, $400{\mu}g/ml$ : 12.747%), Polygonum bistorta L.($50{\mu}g/ml$ : 45.554%, $100{\mu}g/ml$ : 45.554%, $200{\mu}g/ml$ : 0.0%, $400{\mu}g/ml$ : 0.0%) and Psoralea corylifolia L.($50{\mu}g/ml$ : 86.591%, $100{\mu}g/ml$ : 81.307%, $200{\mu}g/ml$ : 24.801%, $400{\mu}g/ml$ : 3.111%) highly depressed cell viability more than the other ingredients. (${\alpha}$<0.05) 2. Cell Proliferation assay Proliferation assay with ingredients of Fuzhengfangaitang on ECV-304 showed that Crataegus pinnatifuda BGE ($50{\mu}g/ml$: 63.276%, $100{\mu}g/ml$ : 64.092%, $200{\mu}g/ml$ : 68.966% $400{\mu}g/ml$ : 38.517%, ED50=$296.974{\mu}g/ml$), Polygonum bistorta L.($50{\mu}g/ml$ : 83.981%, $100{\mu}g/ml$ : 86.997%, $200{\mu}g/ml$ : 58.780%, $400{\mu}g/ml$ : 26.408%), ED50=$266.725{\mu}g/ml$) and Psoralea corylifolia L.($50{\mu}g/ml$ : 103.037%, $100{\mu}g/ml$ : 82.529%, $200{\mu}g/ml$ : 2.829%, $400{\mu}g/ml$ : 0.998%), ED50=$177.369{\mu}g/ml$) depressed cell proliferation more than the other ingredients. 3. Tube Formation assay Compared with the control group, most ingredients of Fuzhengfangaitang did not remarkably inhibited the Tube Formation assay of ECV-304 at the dose of $100{\mu}g/ml$. But, Polygonum bistorta L. highly inhibited the tube formation of ECV -304 at the lower dose of $50{\mu}g/ml$. 4. Rat Aortic Ring assay In comparison with the control group, Scutellaria barbata D. DON., root of Polygonum bistorta L. and Psoralea corylifolia L. restricted the angiogenesis of the rat aortic ring at the dose of $100{\mu}g/ml$. And the other ingredients of Fuzhengfangaitang did not restricted the angiogenesis of the rat aortic ring at that dose. Especially, Polygonum bistorta L. highly inhibited the angiogenesis of the rat aortic ring at the lower dose of $50{\mu}g/ml$. From our research, the anti-angiogenic effects of the ingredients of Fuzhengfangaitang was proven. Moreover, it will be helpful for designing more effective prescription for anti angiogenesis.

키워드

참고문헌

  1. 병리학 대한병리학회
  2. 내과학 해리슨 내과학 편집 위원회
  3. 종양학 서울대학교 의과대학
  4. 예방의학과 공중보건 예방의학과 공중보건 편찬위원회
  5. 암예방 및 치료를 위한 한의학적 연구 한국한의학연구원
  6. 경희대학교 대학원 석사학위논문 沒藥散이 혈관신생 억제에 미치는 효과에 대한 연구 姜大寅
  7. 경희대학교 대학원 석사학위논문 桂枝가 Angiogenesis의 억제기전에 미치는 영향 姜玧熙
  8. 경희대학교 대학원 석사학위논문 加味慈桃丸의 angiogenesis 억제효과에 관한 실험적 연구 姜顯淑
  9. 경희대학교 대학원 박사학위논문 活絡效靈丹이 Angiogenesis 억제기전에 미치는 영향 羅琪煥
  10. 경희대학교 대학원 석사학위논문 鬱金이 Angiogenesis 억제기전에 미치는 영향 成熙根
  11. 경희대학교 대학원 박사학위논문 活絡效靈丹이 암전이 억제에 미치는 영향 孫宗坤
  12. 경희대학교 대학원 박사학위논문 扶正防癌湯이 암전이 억제에 미치는 영향 沈範相
  13. 경희대학교 대학원 박사학위논문 加味慈桃丸 構成藥物의 血管新生抑制效果에 관한 硏究 王德仲
  14. 경희대학교 대학원 석사학위논문 十全大補湯이 암전이 억제에 미치는 영향 尹在鎬
  15. 경희대학교 대학원 박사학위논문 立安散이 Angiogenesis 억제기전에 미치는 영향 李紀龍
  16. 경희대학교 대학원 석사학위논문 血府逐瘀湯이 癌轉移 抑制에 미치는 영향 李眞華
  17. 경희대학교 대학원 박사학위논문 加味慈桃丸의 항암 및 면역증강효과에 관한 실험적 연구 全英秀
  18. 대전대학교 대학원 박사학위논문 桃紅四物湯加減方의 항암 및 항전이 효과에 관한 연구 趙漢震
  19. 경희대학교 제1회 동양의학 국제심포지움 中國傳統醫學治療癌症的作用和硏究進展 余桂淸
  20. 경희대학교 제1회 동양의학 국제심포지움 中醫中藥治療癌症35年的探索 于爾辛
  21. 中華醫學雜誌 v.1 中國醫學技術院基礎醫學硏究所(等)
  22. 貴州藥訊 v.2 黔南三十二醫院上海醫療隊
  23. 中藥臨床應用 中山醫學院<中藥臨床應用>編寫組
  24. 中醫治癌大成 孟琳升
  25. 中華腫瘤治療大成 潘敏求
  26. 中醫藥抗癌學 潘鴻鴻
  27. 腫瘤專輯 史宇歷;單書健
  28. 抗瘤治驗本草 盛展能
  29. 中藥現代硏究與臨床應用Ⅰ 陰健;郭力弓
  30. 中西醫結合臨床腫瘤內科學 王守章
  31. 中藥藥理與應用 王浴生
  32. 中醫腫瘤學(上) 郁仁存
  33. 抗癌中草藥大辭典 劉春安;彭明
  34. 新醫藥學雜誌 v.6 宋芳吉 等
  35. 抗癌中藥蘂理與應用 李字彬
  36. 中醫藥方治腫瘤特技集成 李俊德;楊通禮
  37. 藥學論文摘要 1978年度 上海地區性藥學學術會議 劉國聲 等
  38. 抗腫瘤中藥的臨床應用 張民慶;공惠明
  39. 段鳳舞腫瘤積驗方 合肥 趙建成
  40. 腫瘤防治通訊 v.2 張鴻翔 等
  41. 中西醫結合雜誌 v.5 no.2 活血化瘀治則抗腫瘤實驗硏究進展 應榮多
  42. 中醫雜誌 v.35 no.3 抗癌中藥的生物治療效應硏究近況 邢雪梅;邢聰;邢磊
  43. J Am Acad Dermatol, v.40 no.6 The antiangiogenic agents TNP-470 and 2-methofyestradiol inhibit the growth of angiosarcoma in mice Arbiser, J.L.(et al)
  44. Clin Cancer Res v.5 no.8 A phasel and pharmacokinetic study of TNP-470administered weekly to patients with advanced cancer Bhargava, p.(et al)
  45. Proc Natl Acad Sci, v.91 no.9 Thalidomide is an inhibitor of angiogenesis D'Amato, R.J.;Loughnan, M.S.;Flynn, E.;Folkman, J.
  46. Cancer Chemother Pharmacol v.43 Thalidomide up regulates prostate specific antigen secretion from LNCaP cells Dixon, S.C.(et al)
  47. J Pharm Sci v.88 no.1 Pharmacokinetics of thalidomide in an elderly prostate cancer population Pigg, W.D.(et al)
  48. J Bio Chem v.267 Angiogenesis Folkman, J.;Shing, Y.
  49. Int Rev Exp Pathol v.16 Relation of vascular proliferation to tumor growth Folkman, F.;Cotran, R.
  50. J Natl Cancer Inst. v.82 What is the evidence that tumors are angiogenesis dependent, Folkman, J.
  51. Boll Soc Ital Biol Sper v.40 no.13 Action of thalidomide on the growth of the chick-embryo tibia in organotypic cultures Franceschini, M.(et al)
  52. Anal Biochem v.102 Electrophoretic analysis of plasminogen activators inpolyacrylamide gels containing sodiumdodecyl sulfate and copolymerized substrates. Heussen, C.;Howdie, E.B.
  53. Clin Cancer Res v.3 no.9 A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix Kudelka, A.P.(et al)
  54. A Novel angiogenesis Inhibitor That Mediates the Suppression of Metastases by a Lewis Lung Carcinoma cell v.79 Michael S.0'Reilly;Lars Holmgren;Yuen Shing;Catherine Chen;Rosalind, A.;Rosenthal;Marsha Moses;William S. Lane;Yihai, Cao.;E. Helene Sage;Judah Folkman Angiostain
  55. Journal of Immunological Methods v.65 no.1-2 Rapid colorimetric assay for cellular growth and survival:application to proliferation and cytotoxicity assays. Mosmann, T.
  56. Cell v.88 Endostatin;an endogenous inhibitor of angiogenesis and tumor growth. 0'Reilly, M.S.;Boehm, T.;Shing, Y.;Fukai, N.;Vasios, G.;Lane, W.S.;Flynn, E.;Birkhead, J.R.;01sen, B.R.;Folkman J.
  57. Tumori v.85 no.1 Regression of metastatic breast cancer in a patient treated with the anti-angiogenic drug TNP-470 Offodile, R.(et al)
  58. Biophys. Res. Comm. v.181 Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitor, Biochem Oikawa, T.;Hasegawa, M.;Shimamura, M.;Ashino-Fuse H.;Murota, S.I.;Morita, I.
  59. Cancer Invasion and Metastases Sugarbaker, E.V.;Weingard, B.N.;Roseman, J.M.;Liotta, L.A.;Hart, I.R.(ed.)
  60. Am J Pathol, v.152 no.2 Activation of coagulation in situ of clotting proteins and vascular endothelial growth factor in human cancer Shoji, M.;Hnacock, W.W.;Abe, K.;Micko, C.;Casper, K.A.;Baine, R.M.;Wllcox, J.N.;Danave, I.;Dillehay, D.L.;Matthews, E.;Contrino, J.;Morrissey, J.H.;Cordon, S.;Edgington, T.S.;Kudryk, B.;Kreutzer, D.L.;Rickles, F.R.
  61. In Vitro Cellular & Developmental Biology v.26 Spontaneous transformation and immortalization of human endothelial cells. Takahashi, K.;Sawasaki, Y.;Hata, J.;Mukai, K.;Goto, T.
  62. In Vitro Cellular & Developmental Biology v.28A no.6 Rare spontaneously transformed human endothelial cell line provides useful research tool [letter]. Takahasi, K.;Sawasaki, Y.
  63. Exp, Pathol Inhibitory effects of antiangiogenic agents on neovascularization Tanaka, N.G.;Sakamoto, N.;Tohgo, A.;Nishiyama, Y.;Ogawa, H.
  64. Breast Cancer Res Treat v.55 no.2 Synergistic action of apoptosis induced by eicosapentaenoic acid and TNP-470 on human breast cancer cells, Yamamoto, D.(et al)
  65. Int J Cancer v.75 no.5 Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells;conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Zucher, S,;Mirza, H.;Conner, C.E.;Lorenz, A.F.;Drews, M.H.;Bahou, W.F.;Jesty, J.